Get started
Rani Therapeutics Holdings, Inc.RR

Rani Therapeutics Holdings, Inc.

1.45USDR
−0.08−5.23%
Last update at 19:59 GMT
USD
No tradesPost-market
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

RANI chart


Full chart

RANI upcoming earnings


Next report date
≈
March 19
Report period
Q4 2024
EPS estimate
−0.27 USD
Revenue estimate
0.00 USD

Key stats


Market capitalization
‪83.07 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.06 USD
Net income (FY)
‪−33.97 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪22.61 M‬
Beta (1Y)
0.64

Employees


Employees (FY)
140
Change (1Y)
−23 −14.11%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−242.64 K‬ USD

About Rani Therapeutics Holdings, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Talat Imran
Website
ranitherapeutics.com
Headquarters
San Jose
Founded
2012
FIGI
BBG011R6PZ44
Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.

Financials


Performance
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−10.00 M‬‬
‪‪−7.50 M‬‬
‪‪−5.00 M‬‬
‪‪−2.50 M‬‬
‪0.00‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−14.00 M‬‬
‪‪−10.50 M‬‬
‪‪−7.00 M‬‬
‪‪−3.50 M‬‬
‪0.00‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−6.80 M‬‬
‪‪−5.10 M‬‬
‪‪−3.40 M‬‬
‪‪−1.70 M‬‬
‪0.00‬
Debt level and coverage
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪‪−15.00 M‬‬
‪0.00‬
‪‪15.00 M‬‬
‪‪30.00 M‬‬
‪‪45.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Mar 19, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪−0.40‬
‪−0.30‬
‪−0.20‬
‪−0.10‬
‪0.00‬
Actual
Estimate

RANI news



No news here

Looks like there's nothing to report right now

Reload

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RANI is 1.45 USD — it has decreased by −5.23% in the past 24 hours. Watch Rani Therapeutics Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rani Therapeutics Holdings, Inc. stocks are traded under the ticker RANI.
RANI stock has risen by 5.52% compared to the previous week, the month change is a 2.00% rise, over the last year Rani Therapeutics Holdings, Inc. has showed a −52.60% decrease.
We've gathered analysts' opinions on Rani Therapeutics Holdings, Inc. future price: according to them, RANI price has a max estimate of 17.00 USD and a min estimate of 8.00 USD. Watch RANI chart and read a more detailed Rani Therapeutics Holdings, Inc. stock forecast: see what analysts think of Rani Therapeutics Holdings, Inc. and suggest that you do with its stocks.
RANI reached its all-time high on Nov 15, 2021 with the price of 36.27 USD, and its all-time low was 1.24 USD and was reached on Jan 13, 2025. View more price dynamics on RANI chart.
See other stocks reaching their highest and lowest prices.
RANI stock is 5.93% volatile and has beta coefficient of 0.64. Track Rani Therapeutics Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Rani Therapeutics Holdings, Inc. there?
Today Rani Therapeutics Holdings, Inc. has the market capitalization of ‪50.97 M‬, it has decreased by −5.19% over the last week.
Yes, you can track Rani Therapeutics Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
Rani Therapeutics Holdings, Inc. is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
RANI earnings for the last quarter are −0.24 USD per share, whereas the estimation was −0.29 USD resulting in a 17.24% surprise. The estimated earnings for the next quarter are −0.27 USD per share. See more details about Rani Therapeutics Holdings, Inc. earnings.
Rani Therapeutics Holdings, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
RANI net income for the last quarter is ‪−6.78 M‬ USD, while the quarter before that showed ‪−6.80 M‬ USD of net income which accounts for 0.32% change. Track more Rani Therapeutics Holdings, Inc. financial stats to get the full picture.
No, RANI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Mar 13, 2025, the company has 140.00 employees. See our rating of the largest employees — is Rani Therapeutics Holdings, Inc. on this list?
Like other stocks, RANI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rani Therapeutics Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rani Therapeutics Holdings, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rani Therapeutics Holdings, Inc. stock shows the sell signal. See more of Rani Therapeutics Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.